Development and validation of novel nomogram to identify the candidates for extended pelvic lymph node dissection for prostate cancer patients in the robotic era
International Journal of Urology · 2023
DOI: 10.1111/iju.15195 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Urology, 2023. Verfasst von Yusuke Goto und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Chiba University Graduate School of Medicine, Chiba, Japan. Hauptthemen laut MEDLINE: Robotics, Robotic Surgical Procedures, Prostatic Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Objectives
To determine candidates for extended pelvic lymph node dissection using a novel nomogram to assess the risk of lymph node invasion in Japanese prostate cancer patients in the robotic era.
Methods
A total of 538 patients who underwent robot‐assisted radical prostatectomy with extended pelvic lymph node dissection in three hospitals were retrospectively analyzed. Medical records were reviewed uniformly and the following data collected: prostate‐specific antigen, age, clinical T stage, primary and secondary Gleason score at prostate biopsy, and percentage of positive core numbers. Finally, data from 434 patients were used for developing the nomogram and data from 104 patients were used for external validation.
Results
Lymph node invasion was detected in 47 (11%) and 16 (15%) patients in the development and validation set, respectively. Based on multivariate analysis, prostate‐specific antigen, clinical T stage ≥3, primary Gleason score, grade group 5, and percentage of positive cores were selected as variables to incorporate into the nomogram. The area under the curve values were 0.781 for the internal and 0.908 for the external validation, respectively.
Conclusions
The present nomogram can help urologists identify candidates for extended pelvic lymph node dissection concomitant with robot‐assisted radical prostatectomy among patients with prostate cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Chiba University Graduate School of Medicine, Chiba, Japan.
- Department of Urology, Toho University Sakura Medical Center, Chiba, Japan.
- Department of Urology, Yokohama Rosai Hospital, Yokohama, Kanagawa, Japan.
- Department of Urology, Asahi General Hospital, Chiba, Japan.
- Prostate Center and Division of Urology, Chiba Cancer Center, Chiba, Japan.
ORCID-Profile: Yusuke Goto, Shinichi Sakamoto
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Goto, Y., Utsumi, T., Maruo, M., Kurozumi, A., Noro, T., Tanaka, S., Sugawara, S., Chiba, K., Miyazaki, K., Inoue, A., Komaru, A., Fukasawa, S., Imamura, Y., Sakamoto, S., Nakatsu, H., Suzuki, H., Ichikawa, T., & Nagata, M. (2023). Development and validation of novel nomogram to identify the candidates for extended pelvic lymph node dissection for prostate cancer patients in the robotic era. International Journal of Urology. https://doi.org/10.1111/iju.15195
Vancouver
Goto Y, Utsumi T, Maruo M, Kurozumi A, Noro T, Tanaka S, et al. Development and validation of novel nomogram to identify the candidates for extended pelvic lymph node dissection for prostate cancer patients in the robotic era. International Journal of Urology. 2023. doi:10.1111/iju.15195
BibTeX
@article{Goto2023,
author = {Goto, Yusuke and Utsumi, Takanobu and Maruo, Masafumi and Kurozumi, Akira and Noro, Takahide and Tanaka, Satoki and Sugawara, Sho and Chiba, Kazuto and Miyazaki, Kanetaka and Inoue, Atsushi and Komaru, Atsushi and Fukasawa, Satoshi and Imamura, Yusuke and Sakamoto, Shinichi and Nakatsu, Hiroomi and Suzuki, Hiroyoshi and Ichikawa, Tomohiko and Nagata, Maki},
title = {Development and validation of novel nomogram to identify the candidates for extended pelvic lymph node dissection for prostate cancer patients in the robotic era},
journal = {International Journal of Urology},
year = {2023},
doi = {10.1111/iju.15195}
}
EUVIMED